Ertumaxomab (Anti-Human CD22 Recombinant Antibody) 是一种靶向 HER2/neu 和 CD3 的双特异性抗体。Ertumaxomab 激活 Fcγ I/III 型受体，在肿瘤细胞、T 细胞和辅助细胞之间形成三细胞复合体。Ertumaxomab 已被用于研究乳腺癌。
| 生物活性 |
Ertumaxomab (Anti-Human CD22 Recombinant Antibody) is a bispecific antibody targeting HER2/neu and CD3. Ertumaxomab activates Fcγ type I/III-receptors, forming a tri-cell complex among tumour cell, T cell and accessory cell. Ertumaxomab has been used to research breastcancer[1].
|
| CAS 号 |
|
| 储存方式 |
Please store the product under the recommended conditions in the Certificate of Analysis.
|
m.cnreagent.com
